Cargando…
Myocardial Fibrosis in Heart Failure: Anti-Fibrotic Therapies and the Role of Cardiovascular Magnetic Resonance in Drug Trials
All heart muscle diseases that cause chronic heart failure finally converge into one dreaded pathological process that is myocardial fibrosis. Myocardial fibrosis predicts major adverse cardiovascular events and death, yet we are still missing the targeted therapies capable of halting and/or reversi...
Autores principales: | Webber, Matthew, Jackson, Stephen P., Moon, James C., Captur, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584719/ https://www.ncbi.nlm.nih.gov/pubmed/32862327 http://dx.doi.org/10.1007/s40119-020-00199-y |
Ejemplares similares
-
Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction
por: Lewis, Gavin A., et al.
Publicado: (2022) -
Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation
por: Raphael, Claire E., et al.
Publicado: (2021) -
Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction
por: Roy, Clotilde, et al.
Publicado: (2018) -
Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease
por: Podlesnikar, Tomaz, et al.
Publicado: (2017) -
Cardiovascular Magnetic Resonance Imaging in Familial Dilated Cardiomyopathy
por: Lau, Clement, et al.
Publicado: (2023)